{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:54:06Z","timestamp":1785894846313,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004344","name":"Adobe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004344","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011769","name":"Scripps Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031365","name":"Oslo universitetssykehus HF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.virusres.2026.199759","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:42:50Z","timestamp":1781019770000},"page":"199759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK)"],"prefix":"10.1016","volume":"370","author":[{"given":"Elias","family":"Tj\u00e4rnhage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea Kristin","family":"V\u00e5tsveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Raki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nemazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesso","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludvig","family":"Munthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnveig","family":"Grodeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199759_bib0001","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/s41467-019-09549-4","article-title":"Influenza A virus ribonucleoproteins form liquid organelles at endoplasmic reticulum exit sites","volume":"10","author":"Alenquer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2026.199759_bib0002","article-title":"Efficacy and safety of nirmatrelvir\/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis","volume":"95","author":"Amani","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2026.199759_bib0003","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/365347a0","article-title":"SEC12 encodes a guanine-nucleotide-exchange factor essential for transport vesicle budding from the ER","volume":"365","author":"Barlowe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199759_bib0004","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199759_bib0005","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1083\/jcb.201903068","article-title":"LTK is an ER-resident receptor tyrosine kinase that regulates secretion","volume":"218","author":"Centonze","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.virusres.2026.199759_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-021-03959-5","article-title":"Structural basis of cytokine-mediated activation of ALK family receptors","volume":"600","author":"De Munck","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199759_bib0007","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1128\/AAC.02798-13","article-title":"Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro","volume":"58","author":"Denisova","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2026.199759_bib0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmicb.2014.00296","article-title":"Coronavirus infection, ER stress, apoptosis and innate immunity","volume":"5","author":"Fung","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2026.199759_bib0009","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2026.199759_bib0010","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/jm500261q","volume":"57","author":"Johnson","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virusres.2026.199759_bib0011","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3018(16)30091-1","article-title":"Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis","volume":"3","author":"Kanters","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.virusres.2026.199759_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2026.199759_bib0013","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"The Lancet."},{"key":"10.1016\/j.virusres.2026.199759_bib0014","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/JVI.01969-10","article-title":"Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication","volume":"85","author":"Kumar","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199759_bib0015","article-title":"The likelihood of being helped or harmed as a patient-centred tool to assess ALK-inhibitors clinical impact and safety in ALK-addicted non-small cell lung cancer: a systematic review and sensitivity-analysis","volume":"41","author":"Mastrantoni","year":"2024","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.virusres.2026.199759_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of Human immune cell types","volume":"26","author":"Monaco","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.virusres.2026.199759_bib0017","doi-asserted-by":"crossref","first-page":"D129","DOI":"10.1093\/nar\/gkab1030","article-title":"Expression Atlas update: gene and protein expression in multiple species","volume":"50","author":"Moreno","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virusres.2026.199759_bib0018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.virusres.2026.199759_bib0019","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320303121","article-title":"Tropism for ciliated cells is the dominant driver of influenza viral burst size in the human airway","volume":"121","author":"Roach","year":"2024","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.virusres.2026.199759_bib0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/v10090453","article-title":"Host-directed antivirals: a realistic alternative to fight Zika virus","volume":"10","author":"Saiz","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199759_bib0021","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells10030503","article-title":"Assembly and cellular exit of coronaviruses: hijacking an unconventional secretory pathway from the Pre-Golgi intermediate compartment via the Golgi ribbon to the extracellular space","volume":"10","author":"Saraste","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.virusres.2026.199759_bib0022","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.07.006","article-title":"The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression","volume":"157","author":"Schr\u00e4der","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2026.199759_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2021.12.014","article-title":"From high-throughput to therapeutic: host-directed interventions against influenza viruses","volume":"53","author":"Trimarco","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2026.199759_bib0024","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41375-025-02682-8","article-title":"Targeting proteostasis in multiple myeloma through inhibition of LTK","volume":"39","author":"V\u00e5tsveen","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.virusres.2026.199759_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/1753466621995050","article-title":"Respiratory viral infections in the elderly","volume":"15","author":"Watson","year":"2021","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.virusres.2026.199759_bib0026","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199759_bib0027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12885-024-11916-4","article-title":"Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis","volume":"24","author":"Zhao","year":"2024","journal-title":"BMC Cancer"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817022600078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817022600078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:38:11Z","timestamp":1785893891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817022600078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"alternative-id":["S016817022600078X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199759","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK)","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199759"}}